PC
DVAX

PointState Capital’s Dynavax Technologies DVAX Stock Holding History

PointState Capital’s Portfolio DVAX Stock Details DVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-1,316,800
Closed -$16.3M – 104
2018
Q3 		$16.3M Sell
1,316,800
-571,700
-30% -$7.73M 0.22% 65
2018
Q2 		$28.8M Buy
+1,888,500
New +$32.6M 0.33% 62
2018
Q1 		– Sell
-344,364
Closed -$6.44M – 171
2017
Q4 		$6.44M Sell
344,364
-867,336
-72% -$17.4M 0.06% 105
2017
Q3 		$26.1M Sell
1,211,700
-188,300
-13% -$2.98M 0.22% 78
2017
Q2 		$13.5M Buy
+1,400,000
New +$9.09M 0.15% 75
2016
Q2 		– Sell
-300,000
Closed -$5.77M – 116
2016
Q1 		$5.77M Buy
+300,000
New +$6.06M 0.16% 54

Other funds holding DVAX

HM
HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
SM
Senvest Management New York $3.01B AUM 35.7% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
CC
Chicago Capital Chicago, Illinois $4.15B AUM 31.09% 1-Year Est. Return

PointState Capital's DVAX Position: Q4 2018 in Review

PointState Capital sold out of Dynavax Technologies (DVAX) in Q4 2018, closing a stake of 1,316,800 shares — an estimated $16.3M sold.

PointState Capital first reported a position in DVAX in Q1 2016 and held it in 6 quarters. The position peaked at $28.8M in Q2 2018. 132 funds tracked by Wall St. Rank hold DVAX as of Q4 2018.

  • PointState Capital reported no remaining Dynavax Technologies position as of Q4 2018 after selling out during the quarter.
  • PointState Capital sold 1,316,800 Dynavax Technologies shares in Q4 2018, an estimated $16.3M.
  • PointState Capital first reported a position in Dynavax Technologies in Q1 2016 and held it in 6 quarters.
  • PointState Capital's Dynavax Technologies position peaked at $28.8M in Q2 2018.
  • 132 funds tracked by Wall St. Rank held Dynavax Technologies as of Q4 2018.

Based on PointState Capital's 13F filing for Q4 2018, filed 14 Feb 2019.